09:05 AM EST, 11/25/2024 (MT Newswires) -- Clay B Siegall, Director, President and CEO, around November 21, 2024, executed a purchase for 100,000 shares in Immunome ( IMNM ) for $962,181. Following the Form 4 filing with the SEC, Siegall has control over a total of 519,636 shares of the company, with 519,636 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1472012/000141588924027601/xslF345X05/form4-11252024_011157.xml